An inorganic complex that inhibits Mycobacterium tuberculosis enoyl reductase as a prototype of a new class of chemotherapeutic agents to treat tuberculosis

Here we describe the inhibitory activity of IQG607, pentacyano(isoniazid)ferrate(II), on isoniazid-sensitive and isoniazid-resistant strains of Mycobacterium tuberculosis, its oral toxicity, and efforts to adapt IQG607 synthesis to large chemical reactors. IQG607 represents a promising chemotherapeutic agent aiming at the inhibition of a validated and druggable molecular target.

Saved in:
Bibliographic Details
Main Authors: Basso,Luiz A., Schneider,Cristopher Z., Santos,Anderson J. A. B. dos, Santos Jr,André A. dos, Campos,Maria M., Souto,André A., Santos,Diógenes S.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Química 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532010000700026
Tags: Add Tag
No Tags, Be the first to tag this record!